Gelesis Holdings Inc., (GLS): Price and Financial Metrics

Gelesis Holdings Inc., (GLS): $1.53

-0.01 (-0.65%)

POWR Rating

Component Grades













Add GLS to Watchlist
Sign Up

Industry: Biotech



in industry

GLS Stock Price Chart Interactive Chart >

Price chart for GLS

GLS Price/Volume Stats

Current price $1.53 52-week high $12.23
Prev. close $1.54 52-week low $1.45
Day low $1.45 Volume 53,756
Day high $1.59 Avg. volume 287,840
50-day MA $3.94 Dividend yield N/A
200-day MA $6.65 Market Cap 110.76M

Gelesis Holdings Inc., (GLS) Company Bio

Gelesis Holdings Inc., a biotherapeutics company, developing a novel category of treatments for weight management and gut related chronic diseases. It develops a mechanobiology technology platform to treat obesity and other chronic diseases related to the GI pathway. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and chronic idiopathic constipation. Gelesis Holdings Inc. was incorporated in 2006 and is based in Boston, Massachusetts.

GLS Latest News Stream

Event/Time News Detail
Loading, please wait...

GLS Latest Social Stream

Loading social stream, please wait...

View Full GLS Social Stream

Latest GLS News From Around the Web

Below are the latest news stories about Gelesis Holdings Inc that investors may wish to consider to help them evaluate GLS as an investment opportunity.

Plenity® National Media Campaign Kicking Off Today Challenges Restrictive Dieting Norms

BOSTON, January 31, 2022--Who said losing weight has to be miserable? The debut "Who Said?" campaign from Plenity, launching today across the US, challenges many long-held cultural and societal assumptions around weight loss. Plenity’s multichannel campaign will encompass TV, digital, social, and Out of Home (OOH) to grow awareness of Plenity’s novel approach to weight management. The campaign aims to empower the 70% of Americans who struggle with excess weight to think about weight loss in a ne

Yahoo | January 31, 2022

The one-year earnings decline has likely contributed toGelesis Holdings' (NYSE:GLS) shareholders losses of 42% over that period

Investors can approximate the average market return by buying an index fund. While individual stocks can be big...

Yahoo | January 19, 2022

Read More 'GLS' Stories Here

GLS Price Returns

1-mo N/A
3-mo -66.23%
6-mo -84.64%
1-year -84.37%
3-year N/A
5-year N/A
YTD -84.64%
2021 -1.87%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.4807 seconds.